Case number 3:18-cv-13693
VALEANT PHARMACEUTICALS NORTH AMERICA LLC et al v. AUROBINDO PHARMA USA INC. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 15, 2019 | 23 | Order (7) Docket Text: ORDER CONSOLIDATING CASES FOR ALL PURPOSES. Civil Action No. 18-13635 shall be the Lead Case and effective upon entry of this order, all filings in the Consolidated Actions are to be made only in Civil Action No. 18-13635. Signed by Judge Peter G. Sheridan on 4/15/2019. (mmh) |
| Apr 15, 2019 | 22 | Notice of Pro Hac Vice to Receive NEF (1) Docket Text: Notice of Request by Pro Hac Vice James E. Nealon, Esq. to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number 0312-9582231.) (YOUNGELSON, MARC) |
| Apr 15, 2019 | 21 | Order (3) Docket Text: ORDER granting Pro Hac Vice admission as to James E. Nealon, Esq. Signed by Magistrate Judge Lois H. Goodman on 4/15/2019. (jem) |
| Apr 15, 2019 | N/A | Terminated Case (0) Docket Text: ***Civil Case Administratively Terminated. (mmh) |
| Apr 15, 2019 | N/A | Notice of Pro Hac Vice counsel added (0) Docket Text: Pro Hac Vice counsel, JAMES E. NEALON, has been added to receive Notices of Electronic Filing. Pursuant to L.Civ.R. 101.1, only local counsel are entitled to sign and file papers, enter appearances and receive payments on judgments, decrees or orders. (mmh) |
| Apr 12, 2019 | 20 | Main Document (3) Docket Text: APPLICATION/PETITION for Pro Hac Vice Admission for James E. Nealon, Esq. for by AUROBINDO PHARMA LTD., AUROBINDO PHARMA USA INC.. (Attachments: # (1) Certification, # (2) Text of Proposed Order)(YOUNGELSON, MARC) |
| Apr 12, 2019 | 20 | Text of Proposed Order (3) |
| Apr 12, 2019 | 20 | Certification (3) |
| Apr 12, 2019 | 20 | Application/Petition (3) |
| Mar 21, 2019 | N/A | Pretrial Conference - Initial (0) Docket Text: Text Minute Entry for proceedings held before Magistrate Judge Lois H. Goodman: Initial Pretrial Conference held on 3/21/2019 via Conference Call. (if, ) |
| Mar 12, 2019 | 19 | Notice of Pro Hac Vice to Receive NEF (1) Docket Text: Notice of Request by Pro Hac Vice Steven J. Moore, Esq. to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number 0312-9492186.) (YOUNGELSON, MARC) |
| Mar 12, 2019 | N/A | Notice of Pro Hac Vice counsel added (0) |
| Mar 11, 2019 | 18 | Order (3) Docket Text: ORDER Granting leave to appear Pro Hac Vice as to Steven J. Moore. Signed by Magistrate Judge Lois H. Goodman on 3/11/2019. (km) |
| Mar 5, 2019 | 17 | Answer to Counterclaim (9) |
| Mar 5, 2019 | 17 | Main Document (9) Docket Text: ANSWER to Counterclaim by DOW PHARMACEUTICAL SCIENCES, INC., KAKEN PHARMACEUTICAL CO., LTD., VALEANT PHARMACEUTICALS IRELAND LTD., VALEANT PHARMACEUTICALS NORTH AMERICA LLC. (Attachments: # (1) Certificate of Service)(DENI, WILLIAM) |
| Mar 5, 2019 | 17 | Certificate of Service (2) |
| Feb 22, 2019 | 16 | Order (5) Docket Text: ORDER SCHEDULING CONFERENCE: Scheduling Conference set for 3/21/2019 10:00 AM in Trenton - Courtroom 7E before Magistrate Judge Lois H. Goodman. Signed by Magistrate Judge Lois H. Goodman on 2/22/2019. (km) |
| Feb 20, 2019 | N/A | Update Answer Due Deadline (0) Docket Text: Clerk`s Text Order - The document [15] Application for Clerk's Order to Ext Answer/Proposed Order, submitted by KAKEN PHARMACEUTICAL CO., LTD., DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS IRELAND LTD., VALEANT PHARMACEUTICALS NORTH AMERICA LLC has been GRANTED. The answer due date has been set for 3/5/2019. (km) |
| Feb 19, 2019 | 15 | Application for Clerk's Order to Ext Answer/Proposed Order (2) Docket Text: Application and Proposed Order for Clerk's Order to extend time to answer as to Plaintiffs Valeant Pharmaceuticals North America LLC, Valeant Pharmaceuticals Ireland Ltd., Dow Pharmaceutical Sciences, Inc., and Kaken Pharmaceutical Co., Ltd... (DENI, WILLIAM) |
| Jan 28, 2019 | 13 | Answer to Complaint (49) |
| Jan 28, 2019 | 13 | Civil Cover Sheet (2) |
| Jan 28, 2019 | 14 | Corporate Disclosure Statement (aty) (2) Docket Text: Corporate Disclosure Statement by AUROBINDO PHARMA LTD., AUROBINDO PHARMA USA INC. identifying Aurobindo as Corporate Parent.. (YOUNGELSON, MARC) |
| Jan 28, 2019 | 13 | Main Document (49) Docket Text:Aurobindo's ANSWER to Complaint , COUNTERCLAIM against DOW PHARMACEUTICAL SCIENCES, INC., KAKEN PHARMACEUTICAL CO., LTD., VALEANT PHARMACEUTICALS IRELAND LTD., VALEANT PHARMACEUTICALS NORTH AMERICA LLC by AUROBINDO PHARMA LTD., AUROBINDO PHARMA USA INC.. (Attachments: # (1) Civil Cover Sheet)(YOUNGELSON, MARC) |
| Jan 24, 2019 | 12 | Application/Petition (1) |
| Jan 24, 2019 | 12 | Certification of Marc D. Youngelson, Esq. (3) |
| Jan 24, 2019 | 12 | Certification of Steven J. Moore, Esq. (3) |
| Jan 24, 2019 | 12 | Text of Proposed Order (3) |
| Jan 24, 2019 | 12 | Main Document (1) Docket Text: APPLICATION/PETITION for Pro Hac Vice Admission for by All Defendants. (Attachments: # (1) Certification of Marc D. Youngelson, Esq., # (2) Certification of Steven J. Moore, Esq., # (3) Text of Proposed Order)(YOUNGELSON, MARC) |
| Dec 6, 2018 | 11 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by JUSTIN JAMES HASFORD on behalf of KAKEN PHARMACEUTICAL CO., LTD. (HASFORD, JUSTIN) |
| Dec 5, 2018 | 10 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE Returned Executed by VALEANT PHARMACEUTICALS NORTH AMERICA LLC, KAKEN PHARMACEUTICAL CO., LTD., DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS IRELAND LTD.. AUROBINDO PHARMA LTD. waiver sent on 11/28/2018, answer due 2/26/2019. (LOWER, J.) |
| Dec 5, 2018 | 9 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE Returned Executed by VALEANT PHARMACEUTICALS NORTH AMERICA LLC, KAKEN PHARMACEUTICAL CO., LTD., DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS IRELAND LTD.. AUROBINDO PHARMA USA INC. waiver sent on 11/28/2018, answer due 1/28/2019. (LOWER, J.) |
| Dec 5, 2018 | 8 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by J. BRUGH LOWER on behalf of DOW PHARMACEUTICAL SCIENCES, INC., KAKEN PHARMACEUTICAL CO., LTD., VALEANT PHARMACEUTICALS IRELAND LTD., VALEANT PHARMACEUTICALS NORTH AMERICA LLC (LOWER, J.) |
| Sep 13, 2018 | 7 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by MARC D. YOUNGELSON on behalf of All Defendants (YOUNGELSON, MARC) |
| Sep 10, 2018 | 6 | AO120 Patent/Trademark Form (1) Docket Text: AO120 Patent Form filed. (kas, ) |
| Sep 10, 2018 | 5 | AO120 Patent/Trademark Form (1) Docket Text: AO120 Patent Form filed. (kas, ) |
| Sep 10, 2018 | 4 | Summons Issued (2) Docket Text: SUMMONS ISSUED as to AUROBINDO PHARMA LTD., AUROBINDO PHARMA USA INC.. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (kas, ) |
| Sep 10, 2018 | N/A | Add and Terminate Judges (0) Docket Text: Judge Peter G. Sheridan and Magistrate Judge Lois H. Goodman added. (kas, ) |
| Sep 7, 2018 | 1 | Complaint (25) |
| Sep 7, 2018 | 3 | Corporate Disclosure Statement (aty) (1) Docket Text: Corporate Disclosure Statement by KAKEN PHARMACEUTICAL CO., LTD.. (DENI, WILLIAM) |
| Sep 7, 2018 | 2 | Corporate Disclosure Statement (aty) (1) Docket Text: Corporate Disclosure Statement by DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS IRELAND LTD., VALEANT PHARMACEUTICALS NORTH AMERICA LLC identifying Bausch Health Companies Inc. as Corporate Parent.. (DENI, WILLIAM) |
| Sep 7, 2018 | 1 | L. Civ. R. 11.2 Certification (2) |
| Sep 7, 2018 | 1 | Civil Cover Sheet (1) |
| Sep 7, 2018 | 1 | Exhibit H (11) |
| Sep 7, 2018 | 1 | Exhibit G (17) |
| Sep 7, 2018 | 1 | Exhibit F (14) |
| Sep 7, 2018 | 1 | Exhibit E (11) |
| Sep 7, 2018 | 1 | Main Document (25) Docket Text: COMPLAINT against AUROBINDO PHARMA LTD., AUROBINDO PHARMA USA INC. ( Filing and Admin fee $ 400 receipt number 0312-9009271), filed by VALEANT PHARMACEUTICALS NORTH AMERICA LLC, KAKEN PHARMACEUTICAL CO., LTD., DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS IRELAND LTD.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Civil Cover Sheet, # (10) L. Civ. R. 11.2 Certification)(DENI, WILLIAM) |
| Sep 7, 2018 | 1 | Exhibit D (17) |
| Sep 7, 2018 | 1 | Exhibit C (17) |
| Sep 7, 2018 | 1 | Exhibit B (16) |
| Sep 7, 2018 | 1 | Exhibit A (15) |
| Sep 7, 2018 | 1 | Complaint* (1) |
